NOVO.B.DK

249.2

+0.2%↑

GMAB.DK

1,759

-0.79%↓

HLUNB.DK

43.36

-0.87%↓

ZEAL.DK

302.9

-1.46%↓

AMBUB.DK

67.7

-0.59%↓

NOVO.B.DK

249.2

+0.2%↑

GMAB.DK

1,759

-0.79%↓

HLUNB.DK

43.36

-0.87%↓

ZEAL.DK

302.9

-1.46%↓

AMBUB.DK

67.7

-0.59%↓

NOVO.B.DK

249.2

+0.2%↑

GMAB.DK

1,759

-0.79%↓

HLUNB.DK

43.36

-0.87%↓

ZEAL.DK

302.9

-1.46%↓

AMBUB.DK

67.7

-0.59%↓

NOVO.B.DK

249.2

+0.2%↑

GMAB.DK

1,759

-0.79%↓

HLUNB.DK

43.36

-0.87%↓

ZEAL.DK

302.9

-1.46%↓

AMBUB.DK

67.7

-0.59%↓

NOVO.B.DK

249.2

+0.2%↑

GMAB.DK

1,759

-0.79%↓

HLUNB.DK

43.36

-0.87%↓

ZEAL.DK

302.9

-1.46%↓

AMBUB.DK

67.7

-0.59%↓

Search

Coloplast A-S (Class B)

Ouvert

421.3 -0.28

Résumé

Variation du prix de l'action

24h

Actuel

Min

419.4

Max

423.4

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.492

60.328

BPA

6.32

Rendement du dividende

5.28

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.28%

2.24%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-21B

98B

Ouverture précédente

421.58

Clôture précédente

421.3

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 avr. 2026, 23:33 UTC

Résultats

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 avr. 2026, 22:40 UTC

Résultats

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:11 UTC

Résultats

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 avr. 2026, 21:01 UTC

Résultats

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 avr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 avr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 avr. 2026, 23:16 UTC

Résultats

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 avr. 2026, 23:15 UTC

Résultats

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 avr. 2026, 22:52 UTC

Résultats

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 avr. 2026, 22:51 UTC

Résultats

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 avr. 2026, 22:30 UTC

Résultats

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 avr. 2026, 22:30 UTC

Résultats

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 avr. 2026, 22:29 UTC

Résultats

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 avr. 2026, 22:27 UTC

Résultats

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 avr. 2026, 22:06 UTC

Market Talk
Résultats

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:47 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:37 UTC

Résultats

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 avr. 2026, 21:34 UTC

Résultats

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 avr. 2026, 21:29 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:20 UTC

Market Talk
Résultats

Tesla Expands Manufacturing to Chips -- Market Talk

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat